Revenue
7.86 billion USD
2026-09-26 · USD
Exact inputs and evidence
- Revenue: 7856000000 USD Source
Fundies. English
Medline Inc.
EDGARAnnual consolidated revenue for 2025: about USD 28.43B, using the latest reported figures. The previous period, 2024, was about USD 25.51B.
Latest quarter
Operating margin
6.36%
2026-09-26 · %
Operating cash flow
1.03 billion USD
2026-09-26 · USD
Free cash flow
884 million USD
2026-09-26 · USD
- Cash and cash equivalents
- 2.32 billion USD Source
Exact value
2321000000 USD
- Long-term debt including current maturities
- 12.6 billion USD Derived
- Shares outstanding
- Not available
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-11-04.
Financial data available through: 2025-12-31.
Coverage by financial measure
- Revenue: 3 of 11 periods available· newest 2025-12-31
- Operating income: 3 of 11 periods available· newest 2025-12-31
- Net income: 1 of 11 periods available· newest 2025-12-31
- Operating cash flow: 3 of 11 periods available· newest 2025-12-31
- Capital expenditure: 3 of 11 periods available· newest 2025-12-31
- Total assets: 2 of 11 periods available· newest 2025-12-31
- Total liabilities: 2 of 11 periods available· newest 2025-12-31
- Current assets: 2 of 11 periods available· newest 2025-12-31
- Current liabilities: 2 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 2 of 11 periods available· newest 2025-12-31
- long term debt: No compatible figures in this window
- shares outstanding: No compatible figures in this window
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+11.5%Prior period
USD 25.51 billion
–
Current period
USD 28.43 billion
–
Exact inputs and evidence
28432000000 − 25507000000 = 2925000000 USD
25507000000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source28432000000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-1.4%Prior period
USD 1.77 billion
–
Current period
USD 1.74 billion
–
Exact inputs and evidence
1744000000 − 1769000000 = -25000000 USD
1769000000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source1744000000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+26.3%Prior period
USD 354 million
–
Current period
USD 447 million
–
Exact inputs and evidence
447000000 − 354000000 = 93000000 USD
354000000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source447000000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Net income.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2025 2025-01-01 – 2025-12-31
- Revenue USD 28.43 billion 100% of revenue
- Cost of revenue USD 20.91 billion 74% of revenue
- Operating expenses USD 5.31 billion 19% of revenue
- Operating income USD 2.21 billion 7.8% of revenue
- Tax, interest and other Derived USD 1.05 billion 3.7% of revenue
- Net income USD 1.16 billion 4.1% of revenue
Cash
- Operating cash flow USD 1.74 billion 6.1% of revenue
- Capital expenditure USD 447 million 1.6% of revenue
- Free cash flow Derived USD 1.3 billion 4.6% of revenue
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2023 Not shown: operating income or net income is not reported.
- 2024 Not shown: operating income or net income is not reported.
- 2025 92%
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2023 2023-01-01 – 2023-12-31 | 23231000000 | 21981000000 Derived | 1250000000 | Unavailable | Unavailable | 1410000000 Derived | Source
|
| 2024 2024-01-01 – 2024-12-31 | 25507000000 | 23361000000 Derived | 2146000000 | Unavailable | Unavailable | 1415000000 Derived | Source
|
| 2025 2025-01-01 – 2025-12-31 | 28432000000 | 26220000000 Derived | 2212000000 | 1053000000 Derived | 1159000000 | 1297000000 Derived | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 28.4B 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Revenue | 23231000000 |
|
| 2024 | Revenue | 25507000000 |
|
| 2025 | Revenue | 28432000000 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
11.5% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Year over year | No prior comparable period |
|
| 2024 | Year over year | 9.8% |
|
| 2025 | Year over year | 11.5% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin 7.8% 2025
Net margin 4.1% 2025
Free cash flow margin 4.6% 2025
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Operating margin | 5.4% |
|
| 2024 | Operating margin | 8.4% |
|
| 2025 | Operating margin | 7.8% |
|
| 2023-12-31 | Net margin | Not reported |
|
| 2024-12-31 | Net margin | Not reported |
|
| 2025 | Net margin | 4.1% |
|
| 2023 | Free cash flow margin | 6.1% |
|
| 2024 | Free cash flow margin | 5.5% |
|
| 2025 | Free cash flow margin | 4.6% |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD 1.7B 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Operating cash flow | 1685000000 |
|
| 2024 | Operating cash flow | 1769000000 |
|
| 2025 | Operating cash flow | 1744000000 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
USD 1.3B 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Free cash flow | 1410000000 |
|
| 2024 | Free cash flow | 1415000000 |
|
| 2025 | Free cash flow | 1297000000 |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
49.9% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023-12-31 | Liabilities / assets | Not reported | No source recorded |
| 2024 | Liabilities / assets | 54.1% |
|
| 2025 | Liabilities / assets | 49.9% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
4.29× 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023-12-31 | Current assets / current liabilities | Not reported | No source recorded |
| 2024 | Current assets / current liabilities | 3.39× |
|
| 2025 | Current assets / current liabilities | 4.29× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2023 2023-01-01 – 2023-12-31 | Unavailable Not reported for this period. | USD 1.69 billion Exact valueExact value: 1685000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 275 million Exact valueExact value: 275000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.41 billion Calculation and evidence1685000000 − 275000000 USD Exact free cash flow: 1410000000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | Unavailable Not reported for this period. | USD 1.77 billion Exact valueExact value: 1769000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 354 million Exact valueExact value: 354000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.42 billion Calculation and evidence1769000000 − 354000000 USD Exact free cash flow: 1415000000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | USD 1.16 billion Exact valueExact value: 1159000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.74 billion Exact valueExact value: 1744000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 447 million Exact valueExact value: 447000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.3 billion Calculation and evidence1744000000 − 447000000 USD Exact free cash flow: 1297000000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
11 filings · 784 latest values · 784 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0002046386, 2046386, MDLN, edgar:2046386
Also known as Medline Inc.